search button
Open Access

Substance-P in symptomatic mediopatellar plica as a predictor of patellofemoral pain

  • Authors:
    • Rui He
    • Liu Yang
    • Guangxing Chen
    • Lin Guo
    • Ying Pei

  • View Affiliations

  • Published online on: October 14, 2015     https://doi.org/10.3892/br.2015.531
  • Pages: 21-26

  • Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to investigate the expression of a neuropeptide of symptomatic mediopatellar plica (MP) to prove that there was a significant correlation between the expression of substance-P (SP) in MP and patellofemoral pain. The specimens of synovial plica were obtained by knee arthroscopy. Semi‑quantitative analysis was used to investigate the expression of SP, and compared the innervation density of SP among the three groups: Blank control (asymptomatic plica), positive control (symptomatic plica with other injuries) and experimental (symptomatic plica without other injuries) groups by the paired t‑test, one‑way analysis of variance and Student‑Newman‑Keuls test in 60 patients. The expression levels of SP nerve fibers in the superior plica were 24.60±26.17, 117.36±73.62 and 59.06±44.06 in the blank control, positive control and experimental groups, respectively. The density of nerve fibers in medial plica was 23.23±18.41 in the blank control group, 268.00±71.60 in the positive control group and 255.44±87.91 in the experimental group. The density of nerve fibers of MP was higher compared to that of the superior plica. The density was highest in the positive control group, and lowest in the blank control group in MP. There was a close correlation between the density of SP expression and the degree of patellofemoral pain. The SP expression intensity has an important role in the incidence of patellofemoral pain and is responsible for the pathogenesis of symptomatic MP.
View Figures
View References

Related Articles

Journal Cover

January-2016
Volume 4 Issue 1

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.3
  • Ranked
    (total number of cites)
  • CiteScore: 3.7
  • CiteScore Rank: Q2: #23/79 Pharmacology, Toxicology and Pharmaceutics
  • Source Normalized Impact per Paper (SNIP): 0.742
  • SCImago Journal Rank (SJR): 0.488
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
He R, Yang L, Chen G, Guo L and Pei Y: Substance-P in symptomatic mediopatellar plica as a predictor of patellofemoral pain. Biomed Rep 4: 21-26, 2016
APA
He, R., Yang, L., Chen, G., Guo, L., & Pei, Y. (2016). Substance-P in symptomatic mediopatellar plica as a predictor of patellofemoral pain. Biomedical Reports, 4, 21-26. https://doi.org/10.3892/br.2015.531
MLA
He, R., Yang, L., Chen, G., Guo, L., Pei, Y."Substance-P in symptomatic mediopatellar plica as a predictor of patellofemoral pain". Biomedical Reports 4.1 (2016): 21-26.
Chicago
He, R., Yang, L., Chen, G., Guo, L., Pei, Y."Substance-P in symptomatic mediopatellar plica as a predictor of patellofemoral pain". Biomedical Reports 4, no. 1 (2016): 21-26. https://doi.org/10.3892/br.2015.531